Cardiac Pathophysiology and the Future of Cardiac Therapies in Duchenne Muscular Dystrophy
Duchenne muscular dystrophy (DMD) is a devastating disease featuring skeletal muscle wasting, respiratory insufficiency, and cardiomyopathy. Historically, respiratory failure has been the leading cause of mortality in DMD, but recent improvements in symptomatic respiratory management have extended t...
Main Authors: | Tatyana A. Meyers, DeWayne Townsend |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-08-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/20/17/4098 |
Similar Items
-
Duchenne's/Becker's muscular dystrophy: Analysis of genotype-feno-type correlation in 28 patients
by: Keckarević Milica, et al.
Published: (2002-01-01) -
Dystrophin and the two related genetic diseases, Duchenne and Becker muscular dystrophies
by: Elisabeth Le Rumeur
Published: (2015-07-01) -
Muscular Fatigue in Duchenne Dystrophy
by: J Gordon Millichap
Published: (1995-02-01) -
Eteplirsen in the treatment of Duchenne muscular dystrophy
by: Lim KRQ, et al.
Published: (2017-02-01) -
Novel Cationic Carotenoid Lipids as Delivery Vectors of Antisense Oligonucleotides for Exon Skipping in Duchenne Muscular Dystrophy
by: Vassilia Partali, et al.
Published: (2012-01-01)